We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
153 hedge funds and large institutions have $666M invested in Amneal Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,791% more call options, than puts
Call options by funds: $3.58M | Put options by funds: $92K
55% more capital invested
Capital invested by funds: $430M → $666M (+$236M)
36% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 25
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
6% more funds holding
Funds holding: 144 → 153 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30.3% less ownership
Funds ownership: 66.08% → 35.78% (-30%)
Holders
153
Holders Change
+9
Holders Change %
+6.25%
% of All Funds
2.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
52
Reduced
44
Closed
25
Calls
$3.58M
Puts
$92K
Net Calls
+$3.49M
Net Calls Change
+$2.83M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$17.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$17M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$4.68M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.78M |
| 5 |
BlackRock
New York
|
+$3.63M |
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
-$11.2M |
| 2 |
Goldman Sachs
New York
|
-$3.46M |
| 3 |
Millennium Management
New York
|
-$3.09M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.63M |
| 5 |
JP Morgan Chase
New York
|
-$1.78M |
